• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Scientists Discover Genetic Variants Responsible for Mucinous Ovarian Cancer

Article

Scientists have identified 3 gene variants of HOXD9, which can help explain the development of ovarian cancer.

Scientists at the Keck School of Medicine, University of Southern California, have identified 3 gene variants of HOXD9, which can help explain the development of the fourth most common cause of cancer in the United States, ovarian cancer.

"By finding these genetic markers, we begin to understand more about the biology of the disease itself," said Dr Simon Gayther, the corresponding author on the manuscript that was published in Nature Genetics, in a statement.

The retrospective study was conducted in 1644 women diagnosed with mucinous ovarian cancer and 21000 women without the disease, under the umbrella of the Collaborative Oncological Gene-environment Study, created to determine the risks of breast, ovarian, and prostate cancer.

Read more on ScienceDaily: http://bit.ly/1IiNBKp

Related Videos
Video 15 - "Ensuring Fair Cardiovascular Care for All: Concluding Perspectives on Disparities and Inclusion"
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Raajit Rampal, MD, PhD, screenshot
Ronesh Sinha, MD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Yuqian Liu, PharmD
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Video 7 - "Harnessing Continuous Glucose Monitors for Type 1 Diabetes Management + Closing Words"
dr monica li
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.